Outstanding
Rheumatoid Factors: What Do They Tell Us?
Should Infection Still Be Considered as the Most Likely Triggering Factor for Rheumatoid Arthritis?
The Gut in Ankylosing Spondylitis and Other Spondyloarthropathies: Inflammation Beneath the Surface
Editorial
Rheumatoid Arthritis and Tuberculosis: Time To Take Notice
Rheumatoid Arthritis: Beyond the Lymphocyte
Rheumatoid Arthritis: Time for Trials of Therapeutic Targets
Rheumatoid Factors: What Do They Tell Us?
Rheumatological Aspects of Dance
Shift Happens: Complementary and Alternative Medicine for Rheumatologists
Should Infection Still Be Considered as the Most Likely Triggering Factor for Rheumatoid Arthritis?
Should the Initial Drug Used to Treat OA Pain Be a Nonsteroidal Antiinflammatory Drug?
Should You Be Reading This Journal?
Significance of Increased Circulating Proteasome in Autoimmune Disease
Splenectomy Has a Limited Role in the Management of Lupus with Thrombocytopenia
Stop Using the American College of Rheumatology Criteria in the Clinic
The Challenges of Estimating the National Costs of Osteoarthritis: Are We Making Progress?
The Clinical Significance of IgA Antiphospholipid Antibodies
The Concept of Disease Modification in Spondyloarthropathy
The Experience of Trial Participation
The Genetics of Cytokines in Ankylosing Spondylitis
The Gut in Ankylosing Spondylitis and Other Spondyloarthropathies: Inflammation Beneath the Surface
